MiR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma

FEBS Letters

Volumn 586, Issue 16, 2012, Pages 2396-2403

  Zheng, Yongxia ^a,b   Yin, Lei ^a   Chen, Huan ^a   Yang, Shengsheng ^a   Pan, Chuanyong ^a   Lu, Shan ^a   Miao, Mingyong ^a   Jiao, Binghua ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b JIAXING UNIVERSITY   (China)

Author keywords

HCC; MicroRNA; miR 376a; p85

Indexed keywords

ALPHA FETOPROTEIN; MICRORNA; MICRORNA 376A; PROTEIN P85; PROTEIN P85 ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOLOGICAL FUNCTIONS; CANCER CELL CULTURE; CANCER TISSUE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UPREGULATION;

ALPHA-FETOPROTEINS; ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER; LIVER NEOPLASMS; LIVER REGENERATION; MEMBRANE PROTEINS; MICE; MICE, NUDE; MICRORNAS; TRANSFECTION;

EID: 84864276787     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.05.054     Document Type: Article

References (36)

1. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
2. R. Garzon, G.A. Calin, and C.M. Croce MicroRNAs in cancer Annu. Rev. Med. 60 2009 167 179
3. M. Negrini, L. Gramantieri, and S. Sabbioni MicroRNA involvement in hepatocellular carcinoma Anticancer Agents Med. Chem. 11 6 2011 500 521
4. H. Varnholt The role of microRNAs in primary liver cancer Ann. Hepatol. 7 2 2008 104 113 (Pubitemid 351845519)
5. J.M. Luk, J. Burchard, and C. Zhang Dlk1-Dio3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival J. Biol. Chem. 286 35 2011 30706 30713
6. L. Zender, A. Villanueva, and V. Tovar Cancer gene discovery in hepatocellular carcinoma J. Hepatol. 52 6 2010 921 929
7. Y. Hoshida, S. Toffanin, and A. Lachenmayer Molecular classification and novel targets in hepatocellular carcinoma: recent advancements Semin. Liver Dis. 30 1 2010 35 51
8. H.B. EI-Serag, and K.L. Rudolph Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 7 2007 2557 2576 (Pubitemid 46890874)
9. S. Whittaker, R. Marais, and A.X. Zhu The role of signaling pathways in the development and treatment of hepatocellular carcinoma Oncogene 29 36 2010 4989 5005
10. Y.L. Chen, P.Y. Law, and H.H. Loh Inhibition of PI3K/Akt signaling: an emerging paradigm for targeted cancer therapy Curr. Med. Chem. Anticancer Agents 5 6 2005 575 589 (Pubitemid 41601056)
11. J.A. Fresno Vara, E. Casado, and J. de Castro PI3K/AKT signaling pathway and cancer Cancer Treat. Rev. 30 2 2004 193 204
12. A.J. Philp, I.G. Campbell, and C. Leet The phosphatidylinositol 3-kinase p85alpha gene is an oncogene in human ovarian and colon tumors Cancer Res. 61 20 2001 7426 7429 (Pubitemid 32995029)
13. Q. Zhu, H. Youn, and J. Tang Phosphoinositide 3-OH kinase p85α and p110β are essential for androgen receptor transactivation and tumor progression in prostate cancers Oncogene 27 33 2008 4569 4579
14. J.H. Shi, H.S. Huitfeldt, and Z.H. Suo Growth of hepatocellular carcinoma in the regenerating liver Liver Transpl. 17 7 2011 866 874
15. R. Dayoub, H. Wagner, and F. Bataille Liver regeneration associated protein (ALR) exhibits antimetastatic potential in hepatocellular carcinoma Mol. Med. 17 3-4 2011 221 228
16. K.A. Paschos, and N.C. Bird Liver regeneration and its impact on post-hepatectomy metastatic tumor recurrence Anticancer Res. 30 6 2010 2161 2170
17. T. Li, B. Wan, and J. Huang Comparison of gene expression in hepatocellular carcinoma, liver development, and liver regeneration Mol. Genet. Genomics 283 5 2010 485 492
18. I. Vivanco, and C.L. Sawyers The phosphatidylinositol 3-kinase-AKT Pathway in human cancer Nat. Rev. Cancer 2 7 2002 489 501 (Pubitemid 37328931)
19. J. Satoh, and H. Tabunoki Comprehensive analysis of human microRNA target networks BioData 4 2011 17
20. X. He, and J. Zhang Why do hubs tend to be essential in protein networks? PLoS Genet. 2 6 2006 e88
21. C. Tibiche, and E. Wang MicroRNA regulatory patterns on the human metabolic network Open Syst. Biol. J. 1 1 2008 1 8
22. C.W. Hsu, H.F. Juan, and H.C. Huang Characterization of microRNA-regulated protein- protein interaction network Proteomics 8 10 2008 1975 1979
23. Y. Fu, Q. Zhang, and C. Kang Inhibitory effects of adenovirus mediated Akt1 and PIK3R1 shRNA on the growth of malignant tumor cells in vitro and in vivo Cancer Biol. Ther. 8 11 2009 1002 1009
24. C. Braconi, J.C. Henry, and T. Kogure The role of microRNAs in human liver cancers Semin. Oncol. 38 6 2011 752 763
25. K.J. Riehle, Y.Y. Dan, and J.S. Campbell New concepts in liver regeneration J. Gastroenterol. Hepatol. 26 suppl 1 2011 203 212
26. J. Shu, B.T. Kren, and Z. Xia Genomewide microRNA down-regulation as a negative feedback mechanism in the early phases of liver regeneration Hepatology 54 2 2011 609 619
27. J. Hou, L. Lin, and W. Zhou Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma Cancer Cell 19 2 2011 232 243
28. L. Zhang, S. Volinia, and T. Bonome Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer Proc. Natl. Acad. Sci. U S A 105 19 2008 7004 7009 (Pubitemid 351754520)
29. F. Wang, J. Yu, and G.H. Yang Regulation of erythroid differentiation by miR-376a and its targets Cell Res. 21 8 2011 1196 1209
30. P.J. Johnson, W.M. Melia, and M.K. Palmer Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma Br. J. Cancer 44 4 1981 502 505 (Pubitemid 12231984)
31. S.Y. Peng, W.J. Chen, and P.L. Lai High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations Int. J. Cancer 112 1 2004 44 50 (Pubitemid 39249490)
32. D.W. Thomson, C.P. Bracken, and G.J. Goodall Experimental strategies for microRNA target indentification Nucleic Acid Res. 39 16 2011 6845 6853
33. M. Thomas, J. Lieberman, and A. Lal Desperately seeking microRNA targets Nat. Struct. Mol. Biol. 17 10 2010 1169 1174
34. D.A. Fruman, S.B. Snapper, and C.M. Yballe Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α Science 283 5400 1999 393 397
35. S.M. Gurney, P. Forster, and U. Just Suppression of the PI3K p85α delays embryoid body development and inhibits cell adhesion J. Cell. Biochem. 112 12 2011 3573 3581
36. S.Y. Park, J.H. Lee, and M. Ha MiR-29 miRNAs activate p53 by targeting p85αand CDC42 Nat. Struct. Mol. Biol. 16 1 2009 23 29